The treatment of Arrhythmia & Cough with vitamins

Arrhythmia and Cough: Mitamins custom make quality formulas for the treatment of Arrhythmia & Cough with vitamins. A Arrhythmia & Cough formula will be made to suit you, using quality brand name ingredients. Mitamins produce custom made vitamin and supplement formulas to suit your individual health needs conveniently in one formula, one bottle and one dosage. For assistance, call toll free: 1-866-585-1390
Your Supplements Facts - Covers the formulas above
Supplement Facts

Specially Formulated for: Arrhythmia and Cough

  • Amount Per Serving
    % DV
    Vitamin A
    2500
    IU
    50%
    Vitamin C
    200
    mg
    333%
    Vitamin E
    200
    IU
    667%
    Calcium
    100
    mg
    10%
    Magnesium
    50
    mg
    13%
    Zinc
    10
    mg
    67%
    Copper
    1
    mg
    50%
    CoQ-10
    50
    mg
    *
    Omega - 3 Fatty Acids
    50
    mg
    *
  • Amount Per Serving
    % DV
    Garlic Extract
    50
    mg
    *
    Grape Seed Extract
    50
    mg
    *
    Green Tea Extract
    50
    mg
    *
    Hawthorn Extract
    50
    mg
    *
    Licorice Extract
    250
    mg
    *
    N-Acetyl L-Cysteine
    250
    mg
    *
    Ginger Extract
    100
    mg
    *
    Mullein Extract
    250
    mg
    *
    * Daily Value (DV) not established
Name Your Supplement Bottle - Just how you like it
The current default name is: 
 
(Click in box to change)
Your Perfect Supplement - Custom-made just for you
Formulas form 35 Years of Medical Practice

Arrhythmia and Cough Formulas Details

Customize Your Supplements - Check all that apply
4A Select additional condition(s) you want to address:


4B Select all the medication(s) you are taking:
If your concern or medication is not listed here, use our Formulator, which covers 680 concerns and 1600 drugs, Click here!
Latest Health Related News:
Quark Pharmaceuticals Extends Research Agreement With State University Of New York For Proprietary SiRNA Compounds For Acute Hearing Loss
Quark Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company focused on discovering and developing novel RNA interference-based therapeutics, announced that it has expanded its relationship with the State University of New York at Buffalo, Center for Hearing & Deafness, which is the Company's primary site for the pre-clinical studies of its product candidate, AHLi-11, for the treatment of acute hearing loss.
Study Reports 70% Of Barrett's Esophagus Patients Cured At One-Year Follow-Up In Multi-Center Study
BARRX Medical, Inc. today announced that 70% of the patients enrolled in a multi-center clinical trial were free of a precancerous condition called Barrett's esophagus one year after treatment. The data was published in the February issue of Gastrointestinal Endoscopy, a medical journal for gastroenterologists who perform advanced endoscopic procedures.
This information concerning the support of Arrhythmia and Cough treatments provide basic knowledge which should always be discussed with your own health practitioner.
Any Questions, Call Us Toll Free: 1-866-585-1390
Live Chat System

manufactured In USA

  verisign          Trust E Finalmark

Custom Vitamins and Nutritional Supplements for Supporting Age-Related Cognitive Decline and Aging Treatments